|
|
Volumn 7, Issue 12, 2010, Pages 669-670
|
|
Breast cancer: Challenges, controversies, breakthroughs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRCA1 PROTEIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
INIPARIB;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
UNCLASSIFIED DRUG;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER RESEARCH;
CANCER RESISTANCE;
CANCER SURVIVAL;
DRUG SENSITIVITY;
DRUG TARGETING;
EDITORIAL;
ENZYME INHIBITION;
GENE EXPRESSION;
GENE MUTATION;
GENE TARGETING;
GENETIC SCREENING;
GENOTYPE;
OVARIECTOMY;
PATIENT SAFETY;
PRIORITY JOURNAL;
PUBLICATION;
RADIATION DOSE;
BREAST NEOPLASMS;
FEMALE;
FORECASTING;
HUMANS;
|
|
EID: 78649651322
PISSN: 17594774
EISSN: 17594782
Source Type: Journal
DOI: 10.1038/nrclinonc.2010.192 Document Type: Editorial |
|
Times cited : (128)
|
|
References (0)
|
